These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 9514191)
1. Prevention of acute inducible atrial flutter in dogs by using an ibutilide-polymer-coated pacing electrode. Labhasetwar V; Strickberger SA; Underwood T; Davis J; Levy RJ J Cardiovasc Pharmacol; 1998 Mar; 31(3):449-55. PubMed ID: 9514191 [TBL] [Abstract][Full Text] [Related]
2. Comparative efficacy of intravenous ibutilide versus procainamide for enhancing termination of atrial flutter by atrial overdrive pacing. Stambler BS; Wood MA; Ellenbogen KA Am J Cardiol; 1996 May; 77(11):960-6. PubMed ID: 8644646 [TBL] [Abstract][Full Text] [Related]
3. Epicardial administration of ibutilide from polyurethane matrices: effects on defibrillation threshold and electrophysiologic parameters. Labhasetwar V; Underwood T; Heil RW; Gallagher M; Langberg J; Levy RJ J Cardiovasc Pharmacol; 1994 Nov; 24(5):826-40. PubMed ID: 7532762 [TBL] [Abstract][Full Text] [Related]
4. Comparison of the effects on drug concentrations, electrophysiologic parameters, and termination of atrial fibrillation in dogs when procainamide and ibutilide are delivered into the right atrium versus intravenously. Vereckei A; Warman E; Mehra R; Zipes DP J Cardiovasc Electrophysiol; 2001 Mar; 12(3):330-6. PubMed ID: 11291807 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of ibutilide for termination of atrial fibrillation and flutter. Ellenbogen KA; Clemo HF; Stambler BS; Wood MA; VanderLugt JT Am J Cardiol; 1996 Oct; 78(8A):42-5. PubMed ID: 8903275 [TBL] [Abstract][Full Text] [Related]
7. Antiarrhythmic and electrophysiologic effects of intravenous ibutilide and sotalol in the canine sterile pericarditis model. Buchanan LV; LeMay RJ; Walters RR; Hsu CY; Brunden MN; Gibson JK J Cardiovasc Electrophysiol; 1996 Feb; 7(2):113-9. PubMed ID: 8853021 [TBL] [Abstract][Full Text] [Related]
8. Hybrid therapy of atrial fibrillation. Santini M; Pignalberi C; Ricci R; Calò L Ital Heart J; 2002 Oct; 3(10):571-8. PubMed ID: 12478814 [TBL] [Abstract][Full Text] [Related]
9. Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation. Volgman AS; Carberry PA; Stambler B; Lewis WR; Dunn GH; Perry KT; Vanderlugt JT; Kowey PR J Am Coll Cardiol; 1998 May; 31(6):1414-9. PubMed ID: 9581743 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Ibutilide Repeat Dose Study Investigators. Stambler BS; Wood MA; Ellenbogen KA; Perry KT; Wakefield LK; VanderLugt JT Circulation; 1996 Oct; 94(7):1613-21. PubMed ID: 8840852 [TBL] [Abstract][Full Text] [Related]
11. Effects of ibutilide on canine cardiac pacing threshold and on induction rates of atrial fibrillation. Sun JL; Han R; Guo JH; Li XY; Ma XL; Wang CY Cell Biochem Biophys; 2012 Dec; 64(3):197-203. PubMed ID: 22740072 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: a dose-response study. Ellenbogen KA; Stambler BS; Wood MA; Sager PT; Wesley RC; Meissner MC; Zoble RG; Wakefield LK; Perry KT; Vanderlugt JT J Am Coll Cardiol; 1996 Jul; 28(1):130-6. PubMed ID: 8752805 [TBL] [Abstract][Full Text] [Related]
13. Antiarrhythmic and electrophysiologic effects of ibutilide in a chronic canine model of atrial flutter. Buchanan LV; Turcotte UM; Kabell GG; Gibson JK J Cardiovasc Pharmacol; 1993 Jul; 22(1):10-4. PubMed ID: 7690080 [TBL] [Abstract][Full Text] [Related]
14. Impact of prophylactic i.v. magnesium on the efficacy of ibutilide for conversion of atrial fibrillation or flutter. Kalus JS; Spencer AP; Tsikouris JP; Chung JO; Kenyon KW; Ziska M; Kluger J; White CM Am J Health Syst Pharm; 2003 Nov; 60(22):2308-12. PubMed ID: 14652979 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of ibutilide fumarate for the conversion of atrial arrhythmias after cardiac surgery. VanderLugt JT; Mattioni T; Denker S; Torchiana D; Ahern T; Wakefield LK; Perry KT; Kowey PR Circulation; 1999 Jul; 100(4):369-75. PubMed ID: 10421596 [TBL] [Abstract][Full Text] [Related]
16. Ibutilide with magnesium for conversion of atrial fibrillation or flutter in rheumatic heart disease patients: Ibutilide with magnesium for chemical cardioversion of atrial fibrillation or flutter. Malviya A; Kapoor M; Sivam RKN; Khan SA; Pandey R; Kumar U; Ete T; Mishra A Indian Heart J; 2020; 72(4):283-288. PubMed ID: 32861384 [TBL] [Abstract][Full Text] [Related]
17. Pre-injection of magnesium sulfate enhances the efficacy of ibutilide for the conversion of typical but not of atypical persistent atrial flutter. Steinwender C; Hönig S; Kypta A; Kammler J; Schmitt B; Leisch F; Hofmann R Int J Cardiol; 2010 Jun; 141(3):260-5. PubMed ID: 19136164 [TBL] [Abstract][Full Text] [Related]
18. Effect of ibutilide, a new class III agent, on sustained atrial fibrillation in a canine model of acute ischemia and myocardial dysfunction induced by microembolization. Nabih MA; Prcevski P; Fromm BS; Lavine SJ; Elnabtity M; Munir A; Steinman RT; Meissner MD; Lehmann MH Pacing Clin Electrophysiol; 1993 Oct; 16(10):1975-83. PubMed ID: 7694244 [TBL] [Abstract][Full Text] [Related]
19. Conversion efficacy and safety of repeated doses of ibutilide in patients with atrial flutter and atrial fibrillation. Study Investigators. Abi-Mansour P; Carberry PA; McCowan RJ; Henthorn RW; Dunn GH; Perry KT Am Heart J; 1998 Oct; 136(4 Pt 1):632-42. PubMed ID: 9778066 [TBL] [Abstract][Full Text] [Related]
20. Use of ibutilide for cardioversion of recent-onset atrial fibrillation and flutter in elderly. Gowda RM; Khan IA; Punukollu G; Mendoza C; Wilbur SL; Vasavada BC; Sacchi TJ Am J Ther; 2004; 11(2):95-7. PubMed ID: 14999360 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]